Highbridge Capital Management’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$877K Buy
+75,697
New +$982K 0.02% 240
2025
Q3
– Sell
-6,221
Closed -$612K – 317
2025
Q2
$612K Hold
6,221
– – 0.02% 116
2025
Q1
$547K Sell
6,221
-1,250
-17% -$116K 0.02% 96
2024
Q4
$541K Hold
7,471
– – 0.02% 139
2024
Q3
$590K Hold
7,471
– – 0.02% 129
2024
Q2
$538K Hold
7,471
– – 0.02% 114
2024
Q1
$705K Sell
7,471
-8,910
-54% -$785K 0.03% 109
2023
Q4
$1.2M Sell
16,381
-21,510
-57% -$1.27M 0.05% 103
2023
Q3
$2.52M Buy
+37,891
New +$3.49M 0.1% 93

Other funds holding GOSS

Highbridge Capital Management's GOSS Position: Q3 2026 in Review

Highbridge Capital Management opened a new position in Gossamer Bio (GOSS) in Q3 2026: 75,697 shares worth $877K. The stake represents 0.02% of the portfolio and ranks #240 among its holdings. This is a return to the name: Highbridge Capital Management previously reported a position in GOSS as recently as Q2 2025.

Highbridge Capital Management first reported a position in GOSS in Q3 2023 and has held it in 9 quarters since. The position peaked at $2.52M in Q3 2023. 57 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Highbridge Capital Management held 75,697 shares of Gossamer Bio worth $877K as of Q3 2026.
  • Gossamer Bio was a new Highbridge Capital Management position in Q3 2026.
  • Gossamer Bio made up 0.02% of Highbridge Capital Management's portfolio in Q3 2026, its #240 holding.
  • Highbridge Capital Management first reported a position in Gossamer Bio in Q3 2023 and has held it in 9 quarters since.
  • Highbridge Capital Management's Gossamer Bio position peaked at $2.52M in Q3 2023.
  • 57 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Highbridge Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.